Om

InterCure Ltd. is an Israel-based pharmaceutical cannabis company focused on the production, manufacturing, and distribution of medical cannabis products. Through its subsidiaries, it develops and supplies pharmaceutical-grade dried cannabis inflorescences and cannabis extracts for medical use in Israel and international markets. The company also operates in the broader biomed sector, reflecting a business mix that combines cannabis operations with investments in healthcare-related portfolio companies. InterCure serves patients, healthcare providers, and distribution partners through a vertically integrated model that spans research, cultivation, production, and delivery of cannabis-based therapies. Headquartered in Herzliya, Israel, InterCure plays a significant role in the regulated medical cannabis market by emphasizing clinical-grade standards and licensed production capabilities.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I INTERCURE MED ENDAVU: Køb Intercure ($INCR) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Intercure, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.